ZOLL X Series Monitor Defibrillator Rev H - Manual (Page 22)

C HAPTER 1 G ENERAL I NFORMATION
1-10 www.zoll.com 9650-001355-01 Rev. H
SpO
2
Monitoring
The X Series pulse CO-oximeter, with Masimo Rainbow
®
SET technology and the Rainbow
series of sensors, is intended for use for continuous noninvasive monitoring of functional
oxygen saturation of arterial hemoglobin (SpO
2
), pulse rate, carboxyhemoglobin saturation
(SpCO), and/or methemoglobin saturation (SpMet). The pulse CO-oximeter and accessories
are indicated for use on adult, pediatric, and neonatal patients during both no motion and
motion conditions, and for patients who are well or poorly perfused, in hospitals, hospital-type
facilities, or in mobile environments.
Respiration Monitoring
The X Series is intended for use to continuously monitor respiration rate and to alarm if the rate
falls outside of the range set by the operator. Because the measurement method actually
measures respiratory effort, apnea episodes with continued respiratory effort (such as
obstructive apnea) may not be detected. It is not intended to be used as an apnea monitor. The
patient population will range from newborn (neonate) to adult.
CO
2
Monitoring
The X Series is intended for use to make continuous noninvasive measurement and monitoring
of carbon dioxide concentration of the expired and inspired breath and breath rate. The patient
population will range from newborn (neonate) to adult.
Invasive Pressure Monitoring
The X Series is intended for use to display and make continuous invasive pressure
measurements from any compatible pressure transducer. The primary intended uses are arterial
blood pressure, central venous pressure and intracranial pressure monitoring. Any contra-
indications of the particular transducer selected by the user shall apply. The patient population
will range from newborn (neonate) to adult.
12-Lead Analysis
The 12-lead ECG Analysis is intended for use in acquiring, analyzing and reporting ECG data,
and to provide interpretation of the data for consideration by caregivers. The interpretations of
ECG data offered by the device are only significant when used in conjunction with caregiver
overread as well as consideration of all other relevant patient data. The 12-lead ECG Analysis
is intended for use on adults (> 18 years of age).